6/10/2013

Eisai and Arena Pharmaceuticals' obesity drug Belviq will be available in the U.S. this week, the firms announced. Belviq, with a generic name of lorcaserin, is a 5HT2c-receptor agonist that promotes satiety after meals and reduces sensations of hunger before meals.

Related Summaries